Ovation Science Inc. (OVATF)
- Previous Close
0.0000 - Open
0.0400 - Bid 0.0211 x --
- Ask 0.0759 x --
- Day's Range
0.0400 - 0.0500 - 52 Week Range
0.0101 - 0.0500 - Volume
367,000 - Avg. Volume
16,890 - Market Cap (intraday)
1.253M - Beta (5Y Monthly) 0.73
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada. Ovation Science Inc. operates as a subsidiary of Skinvisible Pharmaceuticals, Inc.
ovationscience.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: OVATF
View MorePerformance Overview: OVATF
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OVATF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OVATF
View MoreValuation Measures
Market Cap
1.09M
Enterprise Value
1.27M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.14
Price/Book (mrq)
--
Enterprise Value/Revenue
15.75
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-387.12%
Return on Equity (ttm)
--
Revenue (ttm)
111.95k
Net Income Avi to Common (ttm)
-641.09k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
9.96k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-143.39k